Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Revenue $ 1,450 $ 1,304
Cost of revenue 1,068 1,129
Gross profit 382 175
Operating expenses:    
Research and development 1,930 1,637
Selling, general and administrative 3,581 4,365
Total operating expenses 5,511 6,002
Loss from operations (5,129) (5,827)
Modification of warrants (287)
Interest expense, net (234) (210)
Other expense, net (65) (91)
Net loss from consolidated companies (5,715) (6,128)
Loss from minority interest in limited liability company (76) (182)
Comprehensive and net loss (5,791) (6,310)
Series B convertible preferred stock dividends (1,119) (989)
Net loss attributable to common stockholders $ (6,910) $ (7,299)
Net loss per share of common stock:    
Basic and diluted (in dollars per share) $ (0.80) $ (8.17)
Weighted average shares used in computing net loss per common share:    
Basic and diluted (in shares) 8,636,120 893,079